Rare diseases
Investigational molecules
Locations
Back to Belgium294 clinical trials in Roeselare, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
BelgiumStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
BelgiumStudy of Elafibranor for Adults with Primary Biliary Cholangitis
BelgiumStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
BelgiumPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
BelgiumStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
BelgiumFirst‑line Study of RMC‑9805 with Investigator’s Choice Chemotherapy Drug Combination vs Chemotherapy Alone in Patients with Metastatic KRAS G12D‑Mutated Pancreatic Adenocarcinoma
BelgiumEfficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study
BelgiumA Study of ABBV-706 to Assess Safety and Efficacy Compared with Standard Drug Combination in Adults with Relapsed or Refractory Small Cell Lung Cancer
BelgiumRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
BelgiumStudy of telisotuzumab adizutecan plus drug combination in adults with refractory metastatic colorectal cancer
BelgiumSafety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on bladder cancer, lung cancer, and various blood cancers. Studies evaluate novel combination therapies and targeted treatments.
Research includes innovative immunotherapy combinations and precision medicine approaches.
Clinical investigations targeting hypertriglyceridemia and obesity-related conditions, with emphasis on novel therapeutic approaches.
Studies focus on developing safer and more effective treatments for metabolic conditions.
Studies examining treatments for Alzheimer's disease and multiple sclerosis, with particular attention to innovative therapeutic approaches.
Research aims to improve quality of life and disease management for patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
